Article
CD28-Selective Inhibition Prolongs Non-Human Primate Kidney Transplant Survival
2023-05-05
Abstract excerpt
Costimulation blockade using belatacept results in improved renal function after kidney transplant as well as decreased likelihood of death/graft loss and reduced cardiovascular risk; however, higher rates and grades of acute rejection have prevented its widespread clinical adoption. Treatment with belatacept blocks both positive (CD28) and negative (CTLA-4) T cell signaling. CD28-selective therapies may offer imp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 22a74a25-3fac-58a9-8e19-724ca88eba43
- DOI
- 10.1101/2023.05.03.539333
